Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Ocular Therapeutix, Inc. (OCUL)

Structure Therapeutics Inc. Sponsored ADR and Ocular Therapeutix, Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Ocular Therapeutix, Inc. are of similar size ($1.6B and $1.6B). Structure Therapeutics Inc. Sponsored ADR has the higher net margin (0.00% vs −579.1%) and the lower return on invested capital (−1,371.8% vs 0.00%). Across the 14 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 11 and Ocular Therapeutix, Inc. on 3.

Valuation

Metric GPCR OCUL Biotechnology median
P/E n/m n/m 8.50
P/S n/m 29.69 9.71
P/B 1.12 2.97 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 19.59 9.21
Earnings yield (14.35%) (20.67%) (33.15%)
Free cash flow yield (14.75%) (16.51%) (25.50%)

Profitability

Metric GPCR OCUL Biotechnology median
Gross margin 0.00% 87.11% 65.16%
Operating margin 0.00% (603.04%) 0.00%
Net margin 0.00% (579.10%) 0.00%
Free cash flow margin 0.00% (490.07%) 0.00%
Return on equity (20.21%) (72.99%) (56.36%)
Return on assets (19.17%) (53.70%) (48.04%)
Return on invested capital (1,371.78%) 0.00% 0.00%

Growth

Metric GPCR OCUL Biotechnology median
Revenue growth (TTM) — (8.14%) 6.02%
EPS growth (last fiscal year) (2.47%) (16.39%) 30.26%
Revenue growth, 5-year CAGR — 24.45% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR OCUL Biotechnology median
Debt to equity 0.00 0.14 0.00
Current ratio 20.75 13.11 4.72
Net debt to EBITDA 8.27 2.51 0.96

Dividend

Metric GPCR OCUL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GPCR OCUL Biotechnology median
Market cap 1.58b 1.62b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack